195 related articles for article (PubMed ID: 1637139)
21. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
[TBL] [Abstract][Full Text] [Related]
22. Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.
Go KG; Kamman RL; Mooyaart EL; Heesters MA; Pruim J; Vaalburg W; Paans AM
Neuroradiology; 1995 Apr; 37(3):198-206. PubMed ID: 7603595
[TBL] [Abstract][Full Text] [Related]
23. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
[TBL] [Abstract][Full Text] [Related]
24. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
25. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
[TBL] [Abstract][Full Text] [Related]
26. Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology.
Anderson JH; Strandberg JD; Wong DF; Conti PS; Barker PB; Blackband SJ; Hilton J; Natarajan TK; Dannals RF; Samphilipo MA
Invest Radiol; 1994 Jun; 29(6):597-605. PubMed ID: 8088967
[TBL] [Abstract][Full Text] [Related]
27. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas.
Aronen HJ; Pardo FS; Kennedy DN; Belliveau JW; Packard SD; Hsu DW; Hochberg FH; Fischman AJ; Rosen BR
Clin Cancer Res; 2000 Jun; 6(6):2189-200. PubMed ID: 10873068
[TBL] [Abstract][Full Text] [Related]
28. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
[TBL] [Abstract][Full Text] [Related]
29. Combined hyperpolarized
Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
31. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
32. Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Stanus E; Brotchi J; Hildebrand J
Cancer; 1996 Sep; 78(5):1098-106. PubMed ID: 8780549
[TBL] [Abstract][Full Text] [Related]
33. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
Rozental JM; Levine RL; Nickles RJ
J Neurooncol; 1991 Feb; 10(1):75-83. PubMed ID: 2022974
[TBL] [Abstract][Full Text] [Related]
34. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.
Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Shishido F; Uemura K
Cancer; 1994 May; 73(9):2386-94. PubMed ID: 8168042
[TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography in patients with glioma. A predictor of prognosis.
Alavi JB; Alavi A; Chawluk J; Kushner M; Powe J; Hickey W; Reivich M
Cancer; 1988 Sep; 62(6):1074-8. PubMed ID: 3261622
[TBL] [Abstract][Full Text] [Related]
36. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Tsuyuguchi N
Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
[TBL] [Abstract][Full Text] [Related]
37. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.
Fulham MJ; Bizzi A; Dietz MJ; Shih HH; Raman R; Sobering GS; Frank JA; Dwyer AJ; Alger JR; Di Chiro G
Radiology; 1992 Dec; 185(3):675-86. PubMed ID: 1438744
[TBL] [Abstract][Full Text] [Related]
38. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
39. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET.
Luyten PR; Marien AJ; Heindel W; van Gerwen PH; Herholz K; den Hollander JA; Friedmann G; Heiss WD
Radiology; 1990 Sep; 176(3):791-9. PubMed ID: 2389038
[TBL] [Abstract][Full Text] [Related]
40. Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy.
Heesters MA; Kamman RL; Mooyaart EL; Go KG
J Neurooncol; 1993 Jul; 17(1):27-35. PubMed ID: 8120569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
